Literature DB >> 32281640

Hypertension and associated factors in the Islamic Republic of Iran: a population-based study.

Marzieh Katibeh1,2, Ali Moghaddam3, Mehdi Yaseri4, Dinesh Neupane2, Per Kallestrup2, Hamid Ahmadieh3.   

Abstract

BACKGROUND: Hypertension is a major risk factor for cardiovascular diseases and has a high prevalence in the Eastern Mediterranean Region. AIMS: To estimate the prevalence and awareness of hypertension and its associated factors in a central province of the Islamic Republic of Iran.
METHODS: This cross-sectional study was conducted among 2320 adults aged 40-80 years in Yazd, Islamic Republic of Iran, in 2010-2011. Multivariable logistic regression analysis was performed to calculate the odds ratios (ORs) for exploring the association between hypertension and associated risk factors. Of eligible subjects, 2098 participated in clinical examinations (response rate: 90.4%).
RESULTS: The sex- and age-standardized prevalence of hypertension was 52.8% [95% confidence interval (CI): 49.6-56.1%]. Of 1170 participants with hypertension, 421 were diagnosed for the first time in this survey; therefore, the unawareness proportion was 36.0% (95% CI: 33.2-38.8%). Among known cases (749 of 1170), 68.5% (95% CI: 65.0-71.8%) had uncontrolled blood pressure. Age (OR 70-80 vs. 40-50 years=7.01, 95% CI: 4.01-12.24), obesity (OR=2.78, 95% CI: 2.06-3.75), diabetes (OR=1.46, 95% CI: 1.12-1.89), hyperlipidaemia (OR=1.60, 95% CI: 1.26-2.03) and living in a rural area (OR=1.57, 95% CI: 1.0- 2.45) were significantly associated with hypertension.
CONCLUSIONS: Although age is an inevitable risk factor for hypertension, the high unawareness proportion, uncontrolled hypertension and modifiable risk factors such as obesity, hyperlipidaemia and diabetes demand effective preventive and curative strategies.
Copyright © World Health Organization (WHO) 2020. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Entities:  

Keywords:  Islamic Republic of Iran; hypertension; prevalence; risk factors

Mesh:

Year:  2020        PMID: 32281640     DOI: 10.26719/emhj.19.042

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  2 in total

1.  The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19.

Authors:  Samira Nakhaie; Rostam Yazdani; Mohammadreza Shakibi; Soheila Torabian; Sara Pezeshki; Maliheh Sadat Bazrafshani; Maryam Azimi; Faranak Salajegheh
Journal:  J Hum Hypertens       Date:  2022-07-05       Impact factor: 2.877

2.  Awareness, treatment, and practices of lifestyle modifications amongst diagnosed hypertensive patients attending the tertiary care hospital of Karachi: A cross-sectional study.

Authors:  Sadia Yaqoob; Mahjabeen Yaseen; Furqan Ahmad Jarullah; Amna Saleem; Anmol Mohan; Mohammad Yasir Essar; Shoaib Ahmad
Journal:  Ann Med Surg (Lond)       Date:  2022-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.